- Home
- PRME vs MCS Comparison
PRME vs MCS Comparison
Compare PRME & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | MCS |
|---|---|---|
| Founded | 2019 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.1M | 482.2M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRME | MCS |
|---|---|---|
| Price | $3.74 | $15.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $9.31 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 4.1M | 254.0K |
| Earning Date | 11-07-2025 | 10-31-2025 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $5,977,000.00 | ★ $712,239,000.00 |
| Revenue This Year | $179.58 | $10.32 |
| Revenue Next Year | N/A | $5.27 |
| P/E Ratio | ★ N/A | $63.43 |
| Revenue Growth | ★ 647.13 | 6.27 |
| 52 Week Low | $1.11 | $12.85 |
| 52 Week High | $6.94 | $22.73 |
Technical Indicators
Market Signals| Indicator | PRME | MCS |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 47.84 |
| Support Level | $3.26 | $15.28 |
| Resistance Level | $4.08 | $15.79 |
| Average True Range (ATR) | 0.32 | 0.49 |
| MACD | 0.07 | -0.05 |
| Stochastic Oscillator | 60.98 | 28.36 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About MCS Marcus Corporation (The)
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.